Medtecs International Corporation Limited (9103.TW)

TWD 5.04

(-1.95%)

Revenue Summary of Medtecs International Corporation Limited

Medtecs International Corporation Limited's latest annual revenue in 2023 was 52.63 Million USD , down -6.41% from previous year.
Medtecs International Corporation Limited's latest quarterly revenue in 2024 Q2 was 25.52 Million USD , down -2.2% from previous quarter.
Medtecs International Corporation Limited reported a annual revenue of 56.24 Million USD in annual revenue 2022, down -60.98% from previous year.
Medtecs International Corporation Limited reported a annual revenue of 144.15 Million USD in annual revenue 2021, down -63.99% from previous year.
Medtecs International Corporation Limited reported a quarterly revenue of 52.63 Million USD for 2023 FY, down -6.41% from previous quarter.
Medtecs International Corporation Limited reported a quarterly revenue of 26.53 Million USD for 2023 Q2, up 7.71% from previous quarter.

Annual Revenue Chart of Medtecs International Corporation Limited (2023 - 2009)

Historical Annual Revenue of Medtecs International Corporation Limited (2023 - 2009)

Year	Revenue	Revenue Growth
2023	52.63 Million USD	-6.41%
2022	56.24 Million USD	-60.98%
2021	144.15 Million USD	-63.99%
2020	400.32 Million USD	480.38%
2019	68.97 Million USD	0.99%
2018	68.3 Million USD	10.48%
2017	61.82 Million USD	7.34%
2016	57.59 Million USD	-6.48%
2015	61.58 Million USD	19.34%
2014	51.6 Million USD	-7.68%
2013	55.89 Million USD	6.59%
2012	52.44 Million USD	-3.39%
2011	54.27 Million USD	20.12%
2010	45.18 Million USD	-21.3%
2009	57.42 Million USD	0.0%

Year	Revenue	Revenue Growth
2024 Q2	25.52 Million USD	-2.2%
2023 FY	52.63 Million USD	-6.41%
2023 Q2	26.53 Million USD	7.71%
2023 Q4	26.1 Million USD	-1.65%
2022 Q2	31.6 Million USD	-46.3%
2022 FY	56.24 Million USD	-60.98%
2022 Q4	24.63 Million USD	-22.04%
2021 Q4	58.85 Million USD	-31.01%
2021 Q2	85.3 Million USD	-64.12%
2021 FY	144.15 Million USD	-63.99%
2020 Q2	162.6 Million USD	353.94%
2020 Q4	237.71 Million USD	46.19%
2020 FY	400.32 Million USD	480.38%
2019 Q4	35.82 Million USD	8.04%
2019 Q2	33.15 Million USD	-6.19%
2019 FY	68.97 Million USD	0.99%
2018 Q4	35.34 Million USD	7.21%
2018 FY	68.3 Million USD	10.48%
2018 Q2	32.96 Million USD	11.4%
2017 Q4	29.59 Million USD	-8.2%
2017 Q2	32.23 Million USD	7.3%
2017 FY	61.82 Million USD	7.34%
2016 FY	57.59 Million USD	-6.48%
2016 Q4	30.04 Million USD	9.04%
2016 Q2	27.55 Million USD	-17.5%
2015 FY	61.58 Million USD	19.34%
2015 Q4	33.39 Million USD	18.47%
2015 Q2	28.19 Million USD	9.92%
2014 Q2	25.96 Million USD	12.86%
2014 FY	51.6 Million USD	-7.68%
2014 Q4	25.64 Million USD	-1.22%
2013 Q4	23 Million USD	-30.07%
2013 FY	55.89 Million USD	6.59%
2013 Q2	32.89 Million USD	0.0%
2012 Q4	- USD	0.0%
2012 FY	52.44 Million USD	-3.39%
2011 Q2	- USD	0.0%
2011 FY	54.27 Million USD	20.12%
2011 Q4	- USD	0.0%
2010 FY	45.18 Million USD	-21.3%
2010 Q4	- USD	0.0%
2009 Q4	- USD	0.0%
2009 FY	57.42 Million USD	0.0%

Peer Revenue Comparison of Medtecs International Corporation Limited

Name	Revenue	Revenue Difference
Nang Kuang Pharmaceutical Co., Ltd.	2.15 Billion TWD	97.552%
Maxigen Biotech Inc.	622.11 Million TWD	91.539%
SciVision Biotech Inc.	712.98 Million TWD	92.617%
Bionime Corporation	1.75 Billion TWD	97.002%
Pegavision Corporation	6.78 Billion TWD	99.225%
Visco Vision Inc.	2.39 Billion TWD	97.805%